Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today.
If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.
Now in its 5th year, the Canada: Rapid Response 2017 program provides seed funding for high-risk, high-reward, translational research projects on neurodegenerative diseases of aging.
NEW for 2017:
- Projects may request up to $200,000 per project over up to 18 months.
- Applicants may appear in any role on any number of projects.
There are two stages to the application process: Letters of Intent and Proposals. An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be forwarded to those invited in July 2017.
Parkinson’s and Related Diseases (NOW OPEN)
Alzheimer’s and Related Diseases (NOW OPEN)